Go to
JCI Insight
The deubiquitinase USP44 is a tumor suppressor that protects against chromosome missegregation
Andrew J. Holland and Don W. Cleveland
Find articles by Holland, A. in: JCI | PubMed | Google Scholar
Find articles by Cleveland, D. in: JCI | PubMed | Google Scholar
First published February 1, 2013 - More info
Published in
Volume 123, Issue 2
(February 1, 2013)
J Clin Invest. 2013;123(2):933–933. doi:10.1172/JCI68319.
Copyright © 2013, The American Society for Clinical Investigation.
J Clin Invest. 2013;123(2):933–933. doi:10.1172/JCI68319.
Copyright © 2013, The American Society for Clinical Investigation.
Published
February 1, 2013
; Accepted:
date unavailable
Original citation: J. Clin. Invest. 2012;122(12):4325–4328. doi:10.1172/JCI66420.
Citation for this erratum: J. Clin. Invest. 2013;123(2):933. doi:10.1172/JCI68319.
Figure 1 was incorrect.
The JCI regrets the error.
Follow JCI:
Copyright © 2017 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)
Copyright © 2017 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)